MentionFox
Home › funding signals › Cresilon, Inc.
Form D · on the record

Cresilon — $25M Form D filing, January 2025

Before you sell to, join or invest in Cresilon, Inc.

MentionFox check on Cresilon, Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/cresilon-inc-form-d-25000003

Check Cresilon, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Cresilon, Inc.?

Cresilon, Inc. filed a Form D with the Securities and Exchange Commission on 2025-01-31.

Cresilon, Inc. filed a Form D notice of an exempt securities offering with the SEC on January 31, 2025. The filing reports $25M sold. Its industry group is Biotechnology. It names Joseph Landolina (Executive Officer, Director), Isaac Miller (Executive Officer, Director), Scott Levine (Executive Officer) (SEC Form D, January 31, 2025).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

3 more Biotechnology raises in New York within 90 days ↓

Is this your company?

Key facts

Run the free check on Cresilon, Inc. →

Sell to companies like Cresilon, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Cresilon, Inc.

New Form D on file · 2025-01-31 · the record

$25M
raise on the record
D
filing
237
investors in
NEW YORK
based
Open the record →

What the record says

FilingForm D
Filed2025-01-31
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedBROOKLYN, NEW YORK
CIK1728054
Accession0001728054-25-000001

Pitching, partnering or investing alongside them? See who really runs and owns Cresilon, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Cresilon, Inc., from the filings we hold.

Raised through the same sales agent

Paulson Investment Company, LLC received sales compensation on this raise and on 5 other raises we hold, nearest in date first:

More raises like this

Biotechnology raises by companies based in New York, filed within 90 days of this one, largest first.

What do you want to do with Cresilon, Inc.?

Get the full cited report on Cresilon, Inc.

What the filing shows about Cresilon, Inc.

  • The filing reports $300K of the proceeds going to the company's own executives, directors or promoters.
  • 237 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Cresilon, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Cresilon, Inc.'s address as 122 18TH Street, Brooklyn, NY 11215.

What the filing says

  • Offered: $25,000,000. Sold: $24,999,967. Left to sell: $33. (filing)
  • Investors: 237 had already invested. (filing)
  • Date of first sale: April 18, 2024. (filing)
  • Types of securities: Equity; Options, warrants or other rights to acquire another security. (filing)
  • Item 16, payments to executive officers, directors or promoters: $300,000 of the proceeds is used or proposed to be used for such payments. The filing gives no explanation. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Cresilon, Inc. See pricing

Is Cresilon, Inc. a real, registered company?

Cresilon, Inc. is a registered filer with the SEC (CIK 1728054) and has filed since 2022-10-18. 7 filings are on record, the latest on 2026-06-26.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Cresilon, Inc.?

Cresilon, Inc.'s Form D of 2025-01-31 names Joseph Landolina, Isaac Miller and Scott Levine as its officers, directors or promoters.

How much has Cresilon, Inc. raised?

Its new offerings report $96.10M sold across 6 offerings, as its own filings state.

Filing history · 7 filings on this registrant
Form D · 2022-10-18 · $25MForm D · 2024-10-08 · $17.24MForm D · 2025-01-31 · $25M · this pageForm D · 2025-09-05 · $17.17MForm D · 2025-12-08 · $6.68MForm D · 2026-04-29 · $5MForm D/A, amended · 2026-06-26 · $29M 2022-10-18 2026-06-26

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Biotechnology · by week

Trailing twelve months. 763 filings in Biotechnology, totalled by week.

Want the whole picture on Cresilon, Inc.?

What the filing shows about Cresilon, Inc.

  • The filing reports $300K of the proceeds going to the company's own executives, directors or promoters.
  • 237 investors had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Cresilon, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Cresilon, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Cresilon, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Cresilon, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Cresilon, Inc.: Raised $25M, Form D filed 2025-01-31
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/cresilon-inc-form-d-25000003
Last updated 2026-11-06
Primary record: SEC filing 1 · SEC filing 2
Cresilon raised $25M — SEC Form D filing, January 2025. MentionFox, 2026-11-06. https://mentionfox.com/funding/cresilon-inc-form-d-25000003